The virtual event is aimed at any clinicians interested in gaining an in-depth understanding about therapeutic options for patients struggling with sleepiness.
It is estimated that around one in five Australians suffer from a major sleep disorder, such as obstructive sleep apnoea, insomnia, restless legs syndrome, circadian rhythm disorders and central disorders of hypersomnolence.
Hypersomnolence or hypersomnia is a condition characterised by excessive daytime sleepiness or prolonged night-time sleep. A 2017 analysis from Deloitte Access Economics (Deloitte) estimated that insomnia affects around 19% of the Australian population.
The day-long virtual masterclass has a strong clinical focus, and is aimed at sleep and respiratory physicians, general physicians, advanced trainees, psychiatrists, neurologists, psychologists and general practitioners.
About the event
The Hypersomnolence Masterclass features keynote presentations from international and national experts, including Dr Christelle Peyron, Associate Professor David Plante and Dr Lynn Marie Trotti.
Participants will have the opportunity of learning about current and new therapeutic options for patients struggling with sleepiness. Participants of this masterclass can expect to:
- Understand the pathophysiology of hypersomnolence and specifically central disorders of Hypersomnolence.
- Develop and refine diagnostic and therapeutic approach to hypersomnolence and central disorders of hypersomnolence.
- Gain improved understanding of the complex, overlapping conditions that may impact the diagnosis and management of hypersomnolence.
- Understand the importance of a multidisciplinary team approach in the management of hypersomnolence disorders.
Program details
Location: Virtual.
Program: click here.
Registration: click here.
Date: Saturday 31 July 2021, from 9:30 AM to 3:30 PM AEST
Registration fees: ASA Members $330; ASA Student Members $80 and Non-members $600.